Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.
In 2018, the global Sexually Transmitted Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Sexually Transmitted Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexually Transmitted Disease Therapeutics development in United States, Europe and China.
The key players covered in this study
Abbott
Roche
BD
BioMérieux
Bio-Rad
Cepheid
Market segment by Type, the product can be split into
Gonorrhea
Syphilis
Chlamydia
Trichomoniasis
Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sexually Transmitted Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Sexually Transmitted Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Sexually Transmitted Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Research Methodology
Medical care is the effective as well as the guided design of all types of medical services to the people. Medical care generally revolves around service design such as patient’s safety, integrated care and patient-centered care. The topic of medical care also explores innovative and latest ideas on exactly how to develop a team of physicians in areas where medical leadership and qualitative improvement have been given utmost importance. Considering the significance of the medical care industry across the globe, QY Research has delivered impartial, insightful and complete research report which offers a crystal clear picture of prominent as well as niche markets in the industry.
In an attempt to make this report an exclusive one, the expert team of analysts covered the various markets under the medical care industry in detail. Further, they have explored several market dynamics such as trends, opportunities, drivers and restraints to give a transparent view of this highly competitive industry. To arrive at market numbers, QY Research’s analysts have evaluated the available data over different parameters. Apart from this, one of the important section which is known as the competitive landscape has also been covered in the report. This section has given information about the top players functioning in the medical care industry.
Medical care industry witnesses major growth in the United States since past few years
The significant regions such as Latin America, North America, Western and Eastern Europe, Middle East and Africa and the Asia Pacific including Japan are included in this report. Apart from this broad category of regions some of the niche countries, particularly in the Asia Pacific such as Malaysia, Indonesia, and Vietnam and in Latin America such as Mexico are evaluated in this report. The US lens on worldwide trends and opportunities for health systems and plans. De-hospitalization and self-aggregation are two prominent forces which are expected to drive the medical industry in the US. In the Asia Pacific region, the medical industry is expected to boom in China and India in the years to come. Increasing population, rising disposable income, and a growing geriatric population are some of the factors, which are responsible for the growth of the medical care industry in the Asia Pacific region.
A lucid analysis of competitive landscape in the medical industry makes QY Research’s report a unique one
As mentioned above, the competitive landscape section is the most significant section in this report and that is the reason the research analysts in QY Research has left no stone unturned while examining the various markets in the medical care industry. This section offers comprehensive information about the product overview, the overview of the company, and key financial and key developments related to that specific company.
Other prominent features of this section include SWOT analysis of selected companies. SWOT analysis helps in providing information about weaknesses and strength, threats and opportunities that are faced by the companies functioning in the medical care industry. Competitive landscape indeed an invaluable part of this report as it includes all the required information to study the key players operating in the medical care industry. A detailed analysis of leading companies’ strategies and their vision to sustain in this highly competitive industry is one of the significant features of this report.
Segmental Analysis
The markets covered under the purview of the medical care industry are generally segmented as, by product, by application, by an end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.
Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, the bottom-up approach has been used by the experts in the medical care industry. While examining different segments of the markets in the medical care industry, the analysts in QY Research have carried out several surveys along with detailed primary research.
Key takeaways from this report
Stakeholders in the medical care industry are following new measures of cost reduction, for example, developing the models of alternative staffing, reduction in supply and administrative cost and shifting patients to outpatient services. Additionally, the key players in the market are also discovering new sources of revenue such as launching new companies, capitalization of intellectual property and commercializing their foreign assets.
QY Research founded in 2007, focuses on IPO and management consulting, chain research of various industries and seminar services and database. The company has its own primary databases such as Industry Association Database, customs export and import database, database of national bureau of statistics and resource from industry experts who have more than ten years’ experience of associating with Research & development industries of consumer goods, energy, Internet and Communication, automotive, medical, and chemicals. QY Research has so far served many Fortune 500 companies.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Gonorrhea
1.4.3 Syphilis
1.4.4 Chlamydia
1.4.5 Trichomoniasis
1.5 Market by Application
1.5.1 Global Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Research and Academic Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sexually Transmitted Disease Therapeutics Market Size
2.2 Sexually Transmitted Disease Therapeutics Growth Trends by Regions
2.2.1 Sexually Transmitted Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Sexually Transmitted Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sexually Transmitted Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Sexually Transmitted Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sexually Transmitted Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Sexually Transmitted Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Sexually Transmitted Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Sexually Transmitted Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
5.2 Sexually Transmitted Disease Therapeutics Key Players in United States
5.3 United States Sexually Transmitted Disease Therapeutics Market Size by Type
5.4 United States Sexually Transmitted Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
6.2 Sexually Transmitted Disease Therapeutics Key Players in Europe
6.3 Europe Sexually Transmitted Disease Therapeutics Market Size by Type
6.4 Europe Sexually Transmitted Disease Therapeutics Market Size by Application
7 China
7.1 China Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
7.2 Sexually Transmitted Disease Therapeutics Key Players in China
7.3 China Sexually Transmitted Disease Therapeutics Market Size by Type
7.4 China Sexually Transmitted Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
8.2 Sexually Transmitted Disease Therapeutics Key Players in Japan
8.3 Japan Sexually Transmitted Disease Therapeutics Market Size by Type
8.4 Japan Sexually Transmitted Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
9.2 Sexually Transmitted Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Sexually Transmitted Disease Therapeutics Market Size by Type
9.4 Southeast Asia Sexually Transmitted Disease Therapeutics Market Size by Application
10 India
10.1 India Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
10.2 Sexually Transmitted Disease Therapeutics Key Players in India
10.3 India Sexually Transmitted Disease Therapeutics Market Size by Type
10.4 India Sexually Transmitted Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Sexually Transmitted Disease Therapeutics Market Size (2014-2019)
11.2 Sexually Transmitted Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Sexually Transmitted Disease Therapeutics Market Size by Type
11.4 Central & South America Sexually Transmitted Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sexually Transmitted Disease Therapeutics Introduction
12.1.4 Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sexually Transmitted Disease Therapeutics Introduction
12.2.4 Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 BD
12.3.1 BD Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sexually Transmitted Disease Therapeutics Introduction
12.3.4 BD Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.3.5 BD Recent Development
12.4 BioMérieux
12.4.1 BioMérieux Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sexually Transmitted Disease Therapeutics Introduction
12.4.4 BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.4.5 BioMérieux Recent Development
12.5 Bio-Rad
12.5.1 Bio-Rad Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sexually Transmitted Disease Therapeutics Introduction
12.5.4 Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.5.5 Bio-Rad Recent Development
12.6 Cepheid
12.6.1 Cepheid Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sexually Transmitted Disease Therapeutics Introduction
12.6.4 Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)
12.6.5 Cepheid Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Sexually Transmitted Disease Therapeutics Key Market Segments
Table Key Players Sexually Transmitted Disease Therapeutics Covered
Table Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Gonorrhea Figures
Table Key Players of Gonorrhea
Figure Syphilis Figures
Table Key Players of Syphilis
Figure Chlamydia Figures
Table Key Players of Chlamydia
Figure Trichomoniasis Figures
Table Key Players of Trichomoniasis
Table Global Sexually Transmitted Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostic Laboratories Case Studies
Figure Research and Academic Laboratories Case Studies
Figure Others Case Studies
Figure Sexually Transmitted Disease Therapeutics Report Years Considered
Table Global Sexually Transmitted Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Sexually Transmitted Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Sexually Transmitted Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Sexually Transmitted Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Sexually Transmitted Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sexually Transmitted Disease Therapeutics Product/Solution/Service
Table Date of Enter into Sexually Transmitted Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Sexually Transmitted Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table United States Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table United States Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure China Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table China Sexually Transmitted Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table China Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table Japan Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure India Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table India Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table India Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Sexually Transmitted Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sexually Transmitted Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sexually Transmitted Disease Therapeutics Market Share (2018-2019)
Table Central & South America Sexually Transmitted Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sexually Transmitted Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Sexually Transmitted Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sexually Transmitted Disease Therapeutics Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table Roche Recent Development
Table BD Company Details
Table BD Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)(Million US$)
Figure BD Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table BD Recent Development
Table BioMérieux Company Details
Table BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)(Million US$)
Figure BioMérieux Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table BioMérieux Recent Development
Table Bio-Rad Company Details
Table Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)(Million US$)
Figure Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table Bio-Rad Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2014-2019)(Million US$)
Figure Cepheid Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2014-2019)
Table Cepheid Recent Development
Table Global Sexually Transmitted Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Sexually Transmitted Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Sexually Transmitted Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sexually Transmitted Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Sexually Transmitted Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Sexually Transmitted Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Sexually Transmitted Disease Therapeutics Market Size by Product in 2025
Table Global Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Sexually Transmitted Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
